Wang JH, Sherry AD, Bazyar S, Sutera P, et al. Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial. J Clin Oncol 2025;43:2059-2068.
PMID: 40334149